About Universitat Autònoma de Barcelona
A new genotyping tool for detecting inversions in the human genome potentially associated with disease is being developed by the comparative and functional genomics group of the Universitat Autònoma de Barcelona (UAB). Together with the UAB Technology Transfer Office, the team is now looking to commercialize the approach and expand its use to many indications.
State of Ownership
Former Head of Communities, Springer Nature
Business Development Executive, Nature Publishing Group
CEO & Co-Founder, Zapnito
Sales Account Executive, Springer Nature
Managing Director, Thoroughly Good Consulting